Jean-Manuel Segura

Prof. Dr. Jean-Manuel Segura

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
VPViktoriia Postupalenko
Viktoriia Postupalenko
LMLéo Marx
Léo Marx
MPMathilde Pantin
Mathilde Pantin
DVDavid Viertl
David Viertl
NGNadège Gsponer
Nadège Gsponer
ONOrigène Nyanguile
Origène Nyanguile
Template-directed methods are emerging as some of the most effective means to conjugate payloads at selective sites of monoclonal antibodies (mAbs). We have previously reported a method based on an engineered Fc-III reactive peptide to conjugate a radionuclide chelator to K317 of antibodies with the concomitant release of the Fc-III peptide ligand. Here, our method was redesigned to target two lysines proximal to the Fc-III binding site, K248 and K439. Using energy minimization predictions and a semi-combinatorial synthesis approach, we sampled multiple Fc-III amino acid substituents of A3, H5, L6 and E8, which were then converted into Fc-III reactive conjugates. Middle-down MS/MS subunit analysis of the resulting trastuzumab conjugates revealed that K248 and K439 can be selectively targeted using the Fc-III reactive variants L6Dap, L6Orn, L6Y and A3K or A3hK, respectively. Across all variants tested, L6Orn-carbonate appeared to be the best candidate, yielding a degree and yield of conjugation of almost 2 and 100% for a broad array of payloads including radionuclide chelators, fluorescent dyes, click-chemistry reagents, pre-targeted imaging reagents, and some cytotoxic small molecules. Furthermore, L6Orn carbonate appeared to yield similar conjugation results across multiple IgG subtypes. In vivo proof of concept was achieved by conjugation of NODAGA to the PD1/PD-L1 immune checkpoint inhibitor antibody atezolizumab, followed by PET imaging of PD-L1 expression in mice bearing PD-L1 expressing tumor xenograft using radiolabeled [64Cu]Cu-atezolizumab.

18 February 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
VPViktoriia Postupalenko
Viktoriia Postupalenko
LMLéo Marx
Léo Marx
DVDavid Viertl
David Viertl
NGNadège Gsponer
Nadège Gsponer
NGNatalia Gasilova
Natalia Gasilova
ONOrigène Nyanguile
Origène Nyanguile
Antibodies are an attractive therapeutic modality for cancer treatment as they allow the increase of the treatment response rate and avoid the severe side effects of chemotherapy. Notwithstanding the strong benefit of antibodies, the efficacy of anti-cancer antibodies can dramatically vary among patients and ultimately result in no response to the treatment. Here, we have developed a novel means to regioselectively label the Fc domain of any therapeutic antibody with a radionuclide chelator in a single step chemistry, with the aim to study by SPECT/CT imaging if the radiolabeled antibody is capable of targeting cancer cells in vivo. A Fc-III peptide was used as bait to bring a carbonate electrophilic site linked to a metal chelator and to a carboxyphenyl leaving group in close proximity with an antibody Fc nucleophile amino acid (K317), thereby triggering the covalent linkage of the chelator to the antibody lysine, with the concomitant release of the carboxyphenyl Fc-III ligand. Using CHX-A′′-DTPA, we radiolabeled trastuzumab with indium-111 and showed in biodistribution and imaging experiments that the antibody accumulated successfully in the SK-OV-3 xenograft tumour implanted in mice. We found that our methodology leads to homogeneous conjugation of CHX-A′′-DTPA to the antibody, and confirmed that the Fc domain can be selectively labeled at K317, with a minor level of unspecific labeling on the Fab domain. The present method can be developed as a clinical diagnostic tool to predict the success of the therapy. Furthermore, our Fc-III one step chemistry concept paves the way to a broad array of other applications in antibody bioengineering.

8 August 2022 in Analytica Chimica Acta
Verified
Journal Article
Open access
EBE.-Diana Bojescu
E.-Diana Bojescu
Denis PrimDenis Prim
Denis Prim
MPMarc Pfeifer
Marc Pfeifer
JSJean-Manuel Segura
Jean-Manuel Segura
Many therapeutic drugs require monitoring of their concentration in blood followed by dose adjustments in order to ensure efficacy while minimizing adverse effects. It would be highly desirable to perform such measurements rapidly and with reduced sample volumes to support point-of-care testing. Here, we demonstrate that the concentration of small therapeutics can be determined in whole blood within paper-like membranes using Fluorescence Polarization Immunoassay (FPIA). Different types of paper-like materials such as glass microfibers, cellulose and filter paper were investigated for artefacts such as scattering or autofluorescence. Accurate determination of the fluorescence polarization of red-emitting fluorophores at sub-nanomolar concentrations was feasible within glass fiber membranes. This enabled the development of a competitive immunoassay for the quantification of the antibiotic tobramycin using only 1 μL of plasma in glass fiber micro-chambers. Furthermore, the same membrane was used for transversal separation of blood cells followed by accurate FPIA read-out at the bottom part of the micro-chamber. For quantification of tobramycin, 1 μL of whole blood was incubated with the immunoassay reagents during only 3 min before deposition in the micro-chamber and analysis. Within the therapeutic window, coefficients of variation were around 20% and recoveries between 80 and 105%. Owing to the simplified procedure requiring no centrifugation, the reduced blood sample volume and the rapid analysis time, we envision that this novel method supports the performance of therapeutic drug monitoring directly at the point of care.

15 October 2000 in Physical Review B
Verified
Journal Article
Closed access
PDF file
RRR. Rodrigues-Herzog
R. Rodrigues-Herzog
FTF. Trotta
F. Trotta
HBH. Bill
H. Bill
JSJean-Manuel Segura
Jean-Manuel Segura
BHB. Hecht
B. Hecht
HGH.-J. Güntherodt
H.-J. Güntherodt
We have investigated the luminescence of CaF2 thin films doped with very low concentrations of Sm2+ ions using scanning confocal optical microscopy at low temperatures. The film morphology was studied independently by atomic force microscopy. The Sm2+ ions are homogeneously distributed in the films and show photobleaching. Unexpectedly, on the film surface strongly luminescent small topographic features are observed that are found to contain Sm3+ by spectral analysis. The formation of Sm3+ is probably due to the presence of oxygen during film growth. In the lowest doped films on-off blinking behavior of isolated luminescent spots provides strong evidence for the first observation of single ions in a crystal.

1 November 2016 in Food Chemistry
Verified
Journal Article
Closed access
JHJulien Héritier
Julien Héritier
BBBenoit Bach
Benoit Bach
PSPatrik Schönenberger
Patrik Schönenberger
VGVanessa Gaillard
Vanessa Gaillard
JDJulien Ducruet
Julien Ducruet
JSJean-Manuel Segura
Jean-Manuel Segura

10 October 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
GGGian Luca De Gregorio
Gian Luca De Gregorio
Denis PrimDenis Prim
Denis Prim
AZAlberto Zavattoni
Alberto Zavattoni
IMItalo Mottini
Italo Mottini
DPDaniele Pezzoli
Daniele Pezzoli
JSJean-Manuel Segura
Jean-Manuel Segura
Cholesterol blood levels in low-density lipoproteins (LDLs) are a key parameter for assessing the risk of cardiovascular diseases. Direct quantification of LDL cholesterol at the point of care would be possible if all other lipoproteins, particularly the high-density lipoproteins (HDLs), could be removed prior to measurement. Here, we investigated whether a molecularly imprinted membrane (MIM) could be used for the solid-phase affinity extraction (SPAE) of HDL in a paper-based lateral flow test. Samples traveled by capillarity through the MIM before reaching a detection zone where LDL cholesterol was quantified enzymatically. MIMs were produced by impregnation of the membrane with a dispersion of molecularly imprinted polymers (MIPs) selective for HDL. MIPs were synthesized using precipitation polymerization and exhibited good selectivity for HDL compared with LDL and an uptake capacity of 5.0–7.0 µg of HDL-C/mg of MIP. The MIM enabled the removal of HDL with an efficiency of typically 68%. However, quantification of LDL cholesterol suffered from strong non-specific binding of LDL, likely due to its inherent colloidal instability. Overall, our results highlight the challenges associated with SPAE of colloidal particles. Furthermore, our study demonstrates a novel, efficient, and potentially generic modality to integrate SPAE into paper-based POC diagnostic tests.